Beigene, ltd. (BGNE)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Operating activities:
Net loss

-1,147,448

-950,578

-829,393

-665,225

-736,986

-674,033

-506,603

-244,827

-147,792

-93,299

-31,617

-184,395

-147,839

-119,217

-108,869

-87,374

-68,891

-57,102

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

22,951

18,617

14,496

12,919

11,560

10,388

9,079

7,934

6,138

4,758

3,177

2,382

2,334

1,909

1,854

1,751

1,632

1,545

0

0

0

Share-based compensation expenses

146,017

134,154

121,770

110,084

96,123

87,127

77,631

65,826

54,267

42,863

30,348

19,800

14,003

10,625

8,846

10,886

10,511

10,211

0

0

0

Provision for doubtful accounts

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized Gain (Loss) on Investments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquired in-process research and development

83,000

69,000

109,000

109,000

89,000

70,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of research and development cost share liability

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of financial instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,514

-2,838

-3,138

-3,152

-1,826

0

0

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Non-cash interest expense

8,760

8,046

7,332

7,464

7,666

7,820

0

0

0

-

-

-

-

121

380

648

927

1,095

0

0

0

Deferred income tax benefits

-8,455

-9,232

-26,485

-14,992

-18,842

-21,949

-8,772

-10,199

-7,775

-5,845

0

0

0

-

-

-

-

-

-

-

-

Other items, net

0

-

-

-

0

-

-

-

-

-

-

0

0

-

-1,093

-1,197

-1,013

-314

0

0

0

Realized gain on available-for-sale securities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash amortization of bond discount

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

8,666

29,822

18,540

24,937

35,491

11,628

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Unbilled receivable

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

15,635

12,311

17,813

42,726

5,642

5,312

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

30,258

-45

18,570

25,473

30,621

38,607

52,215

51,513

40,161

28,880

10,854

5,124

4,141

2,070

1,099

4,230

5,071

2,990

0

0

0

Operating lease right-of-use assets

18,886

11,484

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current assets

13,280

20,782

47,036

46,827

48,358

40,228

37,565

33,256

31,742

29,701

-758

-294

-118

-112

1,492

857

3,469

565

0

0

0

Accounts payable

1,138

2,224

9,742

34,593

21,593

23,470

39,455

52,364

28,337

55,298

25,966

19,024

16,503

2,707

2,840

1,947

1,492

6,186

0

0

0

Advances from customers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-7,133

-

0

0

0

Accrued expenses and other payables

88,595

64,030

57,753

28,639

35,638

50,543

28,891

50,287

28,927

24,978

22,957

8,205

12,890

13,946

17,625

12,924

9,710

7,350

0

0

0

Tax payable

12,677

7,566

7,425

937

-3,119

-3,355

-1,303

-2,881

6,393

7,426

1,632

2,938

2,537

804

0

0

0

-

-

-

-

Deferred revenue

-25,744

-27,982

-31,365

-33,599

-9,558

-9,059

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Operating lease liabilities

17,849

8,482

2,552

17,180

17,579

16,962

44,125

30,639

31,999

31,395

497

958

803

459

136

24

-54

-64

0

0

0

Other long-term liabilities

7,053

9,201

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-920,238

-750,269

-676,982

-544,155

-615,191

-547,717

-260,074

-121,289

-56,038

12,752

-107,137

-138,013

-105,383

-89,513

-80,135

-65,738

-55,973

-39,843

0

0

0

Purchases of property, plant and equipment

89,317

89,612

97,402

93,249

82,415

70,283

65,962

57,802

51,002

46,374

35,503

23,625

25,267

23,502

18,862

13,044

5,385

5,314

0

0

0

Payment for the acquisition of land use right

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Payments to Acquire Debt Securities, Available-for-sale

1,989,125

1,169,300

1,370,001

2,147,555

2,490,816

2,635,686

2,343,680

1,912,572

1,358,837

741,296

0

0

0

-

-

-

-

119,291

0

0

0

Proceeds from sale or maturity of investments

1,428,220

1,882,075

2,398,385

2,475,687

2,630,237

2,177,207

1,508,711

1,130,900

615,744

423,789

271,364

255,097

205,710

183,743

185,032

137,566

98,885

65,698

0

0

0

Purchase of in-process research and development

83,000

69,000

109,000

109,000

89,000

70,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-733,222

554,163

791,298

87,032

-70,845

-637,613

-919,098

-829,788

-794,214

-356,319

-458,796

-13,394

-218,648

-221,848

-43,827

-81,649

-21,794

-58,906

0

0

0

Financing activities:
Proceeds from sale of ordinary shares, net of cost

2,162,407

0

0

0

0

758,001

0

0

0

-

-

-

-

368,877

0

0

0

-

-

-

-

Proceeds from research and development cost share liability

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of public offering cost

-

-

-

-

-

414

0

0

0

-

-

-

-

2,218

0

0

0

-

-

-

-

Proceeds from long-term bank loan

30,794

67,489

67,489

43,704

79,010

42,315

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term bank loan

0

-

-

-

0

-

-

-

-

2,470

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants and rental deferral option

-

-

-

-

-

-

-

-

-

-

-

-

-

2,115

0

0

0

-

-

-

-

Proceeds from option exercises and employee share purchase plan

52,364

47,004

29,190

29,722

29,617

29,662

23,907

14,893

10,878

4,627

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

2,844,884

85,680

92,285

938,399

969,600

1,690,537

1,684,782

1,153,240

1,251,724

490,356

686,000

353,932

213,386

380,902

0

0

0

-

-

-

-

Effect of foreign exchange rate changes, net

-19,989

-9,512

-16,574

-8,611

-3,275

-4,096

-3,324

6,842

8,872

5,299

2,911

397

-111

104

-47

-507

-348

-485

0

0

0

Net increase in cash, cash equivalents, and restricted cash

1,171,435

-119,938

190,027

472,665

280,289

501,111

502,286

209,005

410,344

152,088

122,978

202,922

-110,756

69,645

58,082

32,928

195,139

3,971

0

0

0

Supplemental cash flow information:
Income taxes paid

9,155

8,984

9,161

8,393

12,392

12,361

40,008

40,382

29,539

29,286

1,429

746

76

25

0

0

0

-

-

-

-

Interest paid

4,563

4,315

3,998

3,632

2,766

2,209

1,866

1,309

1,286

1,260

1,256

1,202

1,023

826

637

369

236

134

0

0

0

Supplemental non-cash information:
Conversion of senior promissory note

-

-

-

-

-

-

-

-

-

-

-

-

-

14,693

0

0

0

-

-

-

-

Conversion of deferred rental

-

-

-

-

-

-

-

-

-

-

-

-

-

980

0

0

0

-

-

-

-

Conversion of convertible preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

176,084

0

0

0

-

-

-

-

Exercise of warrants and option

-

-

-

-

-

-

-

-

-

-

-

-

-

3,687

0

0

0

-

-

-

-

Initial public offering costs accrued in accrued expenses and other payables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Acquisitions of equipment included in accounts payable

23,036

29,086

39,340

50,026

50,927

22,105

12,753

8,848

3,651

2,215

3,316

3,448

4,266

2,153

251

65

-36

23

0

0

0

Changes in operating assets and liabilities adjusted through accumulated deficit

-

-

-

-

-

2,291

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-